Literature DB >> 27941769

Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation.

B Kornblit1, K Müller2,3.   

Abstract

Pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) play key roles in initiating innate and adaptive immune responses. Based mainly on animal studies there is growing evidence to suggest that TLRs are involved in the development of chemotherapy-induced mucositis and in the propagation of graft versus host reactions as well as graft versus tumor effects in allogeneic hematopoietic stem cell transplantation (HSCT). In this review we discuss these findings along with the emerging, although still preliminary, clinical evidence, that points to a role of PRRs in determining the outcome of HSCT and new therapeutic perspectives that may be related to this development.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27941769     DOI: 10.1038/bmt.2016.263

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  70 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  Toll-like 4 receptor variant, Asp299Gly, and reduced risk of hemorrhagic cystitis after hematopoietic stem cell transplantation.

Authors:  Bernd Gruhn; Norman Klöppner; Nadine Pfaffendorf-Regler; James Beck; Felix Zintl; Stephan Bartholomä; Klaus-Michael Debatin; Daniel Steinbach
Journal:  Biol Blood Marrow Transplant       Date:  2012-01-30       Impact factor: 5.742

3.  Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.

Authors:  Ahmet H Elmaagacli; Michael Koldehoff; Heidrun Hindahl; Nina K Steckel; Rudolf Trenschel; Rudolf Peceny; Hellmut Ottinger; Peter-Michael Rath; Rudolf Stefan Ross; Michael Roggendorf; Hans Grosse-Wilde; Dietrich W Beelen
Journal:  Transplantation       Date:  2006-01-27       Impact factor: 4.939

4.  Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.

Authors:  Robert R Jenq; Ying Taur; Sean M Devlin; Doris M Ponce; Jenna D Goldberg; Katya F Ahr; Eric R Littmann; Lilan Ling; Asia C Gobourne; Liza C Miller; Melissa D Docampo; Jonathan U Peled; Nicholas Arpaia; Justin R Cross; Tatanisha K Peets; Melissa A Lumish; Yusuke Shono; Jarrod A Dudakov; Hendrik Poeck; Alan M Hanash; Juliet N Barker; Miguel-Angel Perales; Sergio A Giralt; Eric G Pamer; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-11       Impact factor: 5.742

5.  Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.

Authors:  Corey Cutler; Haesook T Kim; Ephraim Hochberg; Vincent Ho; Edwin Alyea; Stephanie J Lee; David C Fisher; David Miklos; Jesse Levin; Stephen Sonis; Robert J Soiffer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2004-05       Impact factor: 5.742

6.  A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.

Authors:  Xilai Ding; Guanglin Bian; Nicholas D Leigh; Jingxin Qiu; Philip L McCarthy; Hong Liu; Semra Aygun-Sunar; Lyudmila G Burdelya; Andrei V Gudkov; Xuefang Cao
Journal:  J Immunol       Date:  2012-10-08       Impact factor: 5.422

7.  Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.

Authors:  Pierre-Yves Bochud; Jason W Chien; Kieren A Marr; Wendy M Leisenring; Arlo Upton; Marta Janer; Stephanie D Rodrigues; Sarah Li; John A Hansen; Lue Ping Zhao; Alan Aderem; Michael Boeckh
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

Review 8.  Oral and intestinal mucositis - causes and possible treatments.

Authors:  M Duncan; G Grant
Journal:  Aliment Pharmacol Ther       Date:  2003-11-01       Impact factor: 8.171

9.  Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9.

Authors:  A H Elmaagacli; M Koldehoff; D W Beelen
Journal:  Bone Marrow Transplant       Date:  2009-03-02       Impact factor: 5.483

Review 10.  Immunomodulation by gut microbiota: role of Toll-like receptor expressed by T cells.

Authors:  Mariagrazia Valentini; Alessia Piermattei; Gabriele Di Sante; Giuseppe Migliara; Giovanni Delogu; Francesco Ria
Journal:  J Immunol Res       Date:  2014-07-24       Impact factor: 4.818

View more
  8 in total

1.  Blocking TIR Domain Interactions in TLR9 Signaling.

Authors:  Artur Javmen; Henryk Szmacinski; Joseph R Lakowicz; Vladimir Y Toshchakov
Journal:  J Immunol       Date:  2018-06-18       Impact factor: 5.422

2.  Targeting Toll-Like Receptors for Cancer Therapy.

Authors:  Marc J Braunstein; John Kucharczyk; Sylvia Adams
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

Review 3.  Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.

Authors:  Kjeld Schmiegelow; Klaus Müller; Signe Sloth Mogensen; Pernille Rudebeck Mogensen; Benjamin Ole Wolthers; Ulrik Kristoffer Stoltze; Ruta Tuckuviene; Thomas Frandsen
Journal:  F1000Res       Date:  2017-04-07

Review 4.  Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.

Authors:  Giuseppe Milone; Claudia Bellofiore; Salvatore Leotta; Giulio Antonio Milone; Alessandra Cupri; Andrea Duminuco; Bruno Garibaldi; Giuseppe Palumbo
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

Review 5.  Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia.

Authors:  Øystein Bruserud; Håkon Reikvam; Annette Katharina Brenner
Journal:  Molecules       Date:  2022-01-23       Impact factor: 4.411

Review 6.  Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?

Authors:  Jacob Rozmus; Sima T Bhatt; Nataliya Prokopenko Buxbaum; Geoffrey D E Cuvelier; Amanda M Li; Carrie L Kitko; Kirk R Schultz
Journal:  Front Pediatr       Date:  2022-03-24       Impact factor: 3.418

7.  Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Maria Ebbesen; Christian Enevold; Anders Juul; Carsten Heilmann; Henrik Sengeløv; Klaus Müller
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

Review 8.  Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease.

Authors:  Nina C Zitzer; Ramiro Garzon; Parvathi Ranganathan
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.